Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Chi-yuan Hsu, MD, MS

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address521 Parnassus Ave, Clinic Sci
    San Francisco CA 94143
    Phone415-353-2379

       Biography 
       Education and Training
      Institution Degree School or Department Year
      Harvard UniversityM.D.School of Medicine1993
       Awards and Honors
      Marin Magazine2012[415] Top Doctor
      American Society for Clinical Investigation2011Member
      Marin Magazine 2013 [415] Top Doctor

       Overview 
       Overview
      EDUCATION
      College: Yale College, BS
      Medical School: Harvard Medical School, MD
      Other Graduate Training: Yale University, MS
      Harvard School of Public Health, MSc
      Internal Medicine Residency: Beth Israel Hospital
      Nephrology Fellowship: Massachusetts General Hospital

      INTERESTS
      The overarching theme of Dr. Hsu's research relates to the study of patients with chronic kidney disease. Previous projects have refined understanding of causes of chronic kidney disease (such as obesity, diabetes and hypertension) and defined consequences of chronic kidney disease (such as anemia, cardiovascular disease and acute kidney injury). Current areas of interest include the impact of acute kidney injury on the course of chronic kidney disease and examining the transition from chronic kidney disease to end-stage renal disease. Dr. Hsu also engages in collaborative translational research of biomarkers in kidney disease.


       ORNG Applications 
       Websites
       In The News
       Awarded Grants
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Park M, Hsu CY. An ACE in the Hole for Patients With Advanced Chronic Kidney Disease? JAMA Intern Med. 2014 Mar 1; 174(3):355-6.
        View in: PubMed
      2. Hsu CY, Liu KD. Cardiovascular Events after AKI: A New Dimension. J Am Soc Nephrol. 2014 Mar; 25(3):425-7.
        View in: PubMed
      3. Lin YC, Bansal N, Vittinghoff E, Go AS, Hsu CY. Determinants of the creatinine clearance to glomerular filtration rate ratio in patients with chronic kidney disease: a cross-sectional study. BMC Nephrol. 2013; 14(1):268.
        View in: PubMed
      4. Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013 Dec 5; 369(23):2183-96.
        View in: PubMed
      5. Parikh CR, Butrymowicz I, Yu A, Chinchilli VM, Park M, Hsu CY, Reeves WB, Devarajan P, Kimmel PL, Siew ED, Liu KD. Urine stability studies for novel biomarkers of acute kidney injury. Am J Kidney Dis. 2014 Apr; 63(4):567-72.
        View in: PubMed
      6. Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI. Association of Kidney Disease Outcomes With Risk Factors for CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2014 Feb; 63(2):236-43.
        View in: PubMed
      7. Fisher H, Hsu CY, Vittinghoff E, Lin F, Bansal N. Comparison of Associations of Urine Protein-Creatinine Ratio Versus Albumin-Creatinine Ratio With Complications of CKD: A Cross-sectional Analysis. Am J Kidney Dis. 2013 Dec; 62(6):1102-8.
        View in: PubMed
      8. Hsu RK, McCulloch CE, Ku E, Dudley RA, Hsu CY. Regional variation in the incidence of dialysis-requiring AKI in the United States. Clin J Am Soc Nephrol. 2013 Sep; 8(9):1476-81.
        View in: PubMed
      9. Hsu RK, Hsu CY. Temporal Trends in Prevalence of CKD: The Glass Is Half Full and Not Half Empty. Am J Kidney Dis. 2013 Aug; 62(2):214-6.
        View in: PubMed
      10. Bansal N, He C, Murphy DP, Johansen KL, Hsu CY. Timing of preemptive vascular access placement: do we understand the natural history of advanced CKD?: an observational study. BMC Nephrol. 2013 May 28; 14(1):115.
        View in: PubMed
      11. Murphy DP, Hsu CY. Estimating glomerular filtration rate: is it good enough? And is it time to move on? Curr Opin Nephrol Hypertens. 2013 May; 22(3):310-5.
        View in: PubMed
      12. Shahinian VB, Hedgeman E, Gillespie BW, Young EW, Robinson B, Hsu CY, Plantinga LC, Burrows NR, Eggers P, Saydah S, Powe NR, Saran R. Estimating prevalence of CKD stages 3-5 using health system data. Am J Kidney Dis. 2013 Jun; 61(6):930-8.
        View in: PubMed
      13. Park M, Vittinghoff E, Liu KD, Shlipak MG, Hsu CY. Urine Biomarkers Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule-1 (KIM-1) Have Different Patterns in Heart Failure Exacerbation. Biomark Insights. 2013; 8:15-8.
        View in: PubMed
      14. Bansal N, Keane M, Delafontaine P, Dries D, Foster E, Gadegbeku CA, Go AS, Hamm LL, Kusek JW, Ojo AO, Rahman M, Tao K, Wright JT, Xie D, Hsu CY. A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol. 2013 Mar; 8(3):355-62.
        View in: PubMed
      15. Tuot DS, Plantinga LC, Judd SE, Muntner P, Hsu CY, Warnock DG, Gutiérrez OM, Safford M, Powe NR, McClellan WM. Healthy behaviors, risk factor control and awareness of chronic kidney disease. Am J Nephrol. 2013; 37(2):135-43.
        View in: PubMed
      16. Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease. Kidney Int. 2013 May; 83(5):909-14.
        View in: PubMed
      17. Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013 Feb 5; 127(5):569-74.
        View in: PubMed
      18. Hsu RK, McCulloch CE, Dudley RA, Lo LJ, Hsu CY. Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Nephrol. 2013 Jan; 24(1):37-42.
        View in: PubMed
      19. Plantinga LC, Tuot DS, Grubbs V, Hsu CY, Powe NR. Chronic kidney disease identification in a high-risk urban population: does automated eGFR reporting make a difference? J Urban Health. 2012 Dec; 89(6):965-76.
        View in: PubMed
      20. Hsu CY. CKD-EPI eGFR categories were better than MDRD categories for predicting mortality in a range of populations. Ann Intern Med. 2012 Nov 20; 157(10):JC5-12.
        View in: PubMed
      21. Bansal N, Whooley MA, Regan M, McCulloch CE, Ix JH, Epel E, Blackburn E, Lin J, Hsu CY. Association between kidney function and telomere length: the heart and soul study. Am J Nephrol. 2012; 36(5):405-11.
        View in: PubMed
      22. Hsu RK, Hsu CY. We can diagnose AKI "early". Clin J Am Soc Nephrol. 2012 Nov; 7(11):1741-2.
        View in: PubMed
      23. Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol. 2012 Oct; 23(10):1725-34.
        View in: PubMed
      24. Anderson AH, Yang W, Hsu CY, Joffe MM, Leonard MB, Xie D, Chen J, Greene T, Jaar BG, Kao P, Kusek JW, Landis JR, Lash JP, Townsend RR, Weir MR, Feldman HI. Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2012 Aug; 60(2):250-61.
        View in: PubMed
      25. Park M, Shlipak MG, Katz R, Agarwal S, Ix JH, Hsu CY, Peralta CA. Subclinical cardiac abnormalities and kidney function decline: the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol. 2012 Jul; 7(7):1137-44.
        View in: PubMed
      26. Bansal N, Hsu CY, Whooley M, Berg AH, Ix JH. Relationship of urine dopamine with phosphorus homeostasis in humans: the heart and soul study. Am J Nephrol. 2012; 35(6):483-90.
        View in: PubMed
      27. Bansal N, Vittinghoff E, Plantinga L, Hsu CY. Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors. J Nephrol. 2012 May-Jun; 25(3):317-24.
        View in: PubMed
      28. Hsu CY. Yes, AKI truly leads to CKD. J Am Soc Nephrol. 2012 Jun; 23(6):967-9.
        View in: PubMed
      29. Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA. Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol. 2012 May; 7(5):844-50.
        View in: PubMed
      30. Molitoris BA, Okusa MD, Palevsky PM, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Faubel SG, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA. Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. Clin J Am Soc Nephrol. 2012 May; 7(5):856-60.
        View in: PubMed
      31. Okusa MD, Molitoris BA, Palevsky PM, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Faubel S, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA. Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials. Clin J Am Soc Nephrol. 2012 May; 7(5):851-5.
        View in: PubMed
      32. Hsu RK, Hsu CY. Acute kidney injury: comment on "trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction". Arch Intern Med. 2012 Feb 13; 172(3):253-4.
        View in: PubMed
      33. Tuot DS, Plantinga LC, Hsu CY, Powe NR. Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes? Am J Nephrol. 2012; 35(2):191-7.
        View in: PubMed
      34. Hsu CY. Brenner and Rector's The Kidney. Chapter 19: Epidemiology of Kidney Disease. 2012; 1:728-741.
      35. Go AS, Bansal N, Chandra M, Lathon PV, Fortmann SP, Iribarren C, Hsu CY, Hlatky MA. Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease. J Am Coll Cardiol. 2011 Oct 4; 58(15):1600-7.
        View in: PubMed
      36. Hsu CY, Propert K, Xie D, Hamm L, He J, Miller E, Ojo A, Shlipak M, Teal V, Townsend R, Weir M, Wilson J, Feldman H. Measured GFR does not outperform estimated GFR in predicting CKD-related complications. J Am Soc Nephrol. 2011 Oct; 22(10):1931-7.
        View in: PubMed
      37. Bansal N, Hsu CY, Chandra M, Iribarren C, Fortmann SP, Hlatky MA, Go AS. Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study. BMC Nephrol. 2011; 12:44.
        View in: PubMed
      38. Plantinga L, Grubbs V, Sarkar U, Hsu CY, Hedgeman E, Robinson B, Saran R, Geiss L, Burrows NR, Eberhardt M, Powe N. Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States. Ann Fam Med. 2011 Sep-Oct; 9(5):423-30.
        View in: PubMed
      39. Coca SG, Cho KC, Hsu CY. Acute kidney injury in the elderly: predisposition to chronic kidney disease and vice versa. Nephron Clin Pract. 2011; 119 Suppl 1:c19-24.
        View in: PubMed
      40. Hsu CY, Bansal N. Measured GFR as "gold standard"--all that glitters is not gold? Clin J Am Soc Nephrol. 2011 Aug; 6(8):1813-4.
        View in: PubMed
      41. Tuot DS, Plantinga LC, Hsu CY, Jordan R, Burrows NR, Hedgeman E, Yee J, Saran R, Powe NR. Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. Clin J Am Soc Nephrol. 2011 Aug; 6(8):1838-44.
        View in: PubMed
      42. Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011 Jun 15; 305(23):2432-9.
        View in: PubMed
      43. Zhang M, Hsu R, Hsu CY, Kordesch K, Nicasio E, Cortez A, McAlpine I, Brady S, Zhuo H, Kangelaris KN, Stein J, Calfee CS, Liu KD. FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study. Ann Intensive Care. 2011; 1(1):21.
        View in: PubMed
      44. Hsu RK, Hsu CY. Proteinuria and reduced glomerular filtration rate as risk factors for acute kidney injury. Curr Opin Nephrol Hypertens. 2011 May; 20(3):211-7.
        View in: PubMed
      45. Bansal N, Hsu CY, Zhao S, Whooley MA, Ix JH. Relation of body mass index to urinary creatinine excretion rate in patients with coronary heart disease. Am J Cardiol. 2011 Jul 15; 108(2):179-84.
        View in: PubMed
      46. Isakova T, Wahl P, Vargas GS, Gutiérrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011 Jun; 79(12):1370-8.
        View in: PubMed
      47. Hsu CY. ACP Journal Club. Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD. Ann Intern Med. 2010 Nov 16; 153(10):JC5-3.
        View in: PubMed
      48. Cho K, Hsu CY. Quantifying severity of chronic kidney disease as a risk factor for acute kidney injury. J Am Soc Nephrol. 2010 Oct; 21(10):1602-4.
        View in: PubMed
      49. Hsu CY. Where is the epidemic in kidney disease? J Am Soc Nephrol. 2010 Oct; 21(10):1607-11.
        View in: PubMed
      50. Go AS, Parikh CR, Ikizler TA, Coca S, Siew ED, Chinchilli VM, Hsu CY, Garg AX, Zappitelli M, Liu KD, Reeves WB, Ghahramani N, Devarajan P, Faulkner GB, Tan TC, Kimmel PL, Eggers P, Stokes JB. The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol. 2010; 11:22.
        View in: PubMed
      51. Townsend RR, Chirinos JA, Parsa A, Weir MA, Sozio SM, Lash JP, Chen J, Steigerwalt SP, Go AS, Hsu CY, Rafey M, Wright JT, Duckworth MJ, Gadegbeku CA, Joffe MP. Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study. Hypertension. 2010 Sep; 56(3):518-24.
        View in: PubMed
      52. Joffe M, Hsu CY, Feldman HI, Weir M, Landis JR, Hamm LL. Variability of creatinine measurements in clinical laboratories: results from the CRIC study. Am J Nephrol. 2010; 31(5):426-34.
        View in: PubMed
      53. Frassetto LA, Hsu CY. Metabolic acidosis and progression of chronic kidney disease. J Am Soc Nephrol. 2009 Sep; 20(9):1869-70.
        View in: PubMed
      54. Liu KD, Lo L, Hsu CY. Some methodological issues in studying the long-term renal sequelae of acute kidney injury. Curr Opin Nephrol Hypertens. 2009 May; 18(3):241-5.
        View in: PubMed
      55. Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordoñez JD, Go AS. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol. 2009 May; 4(5):891-8.
        View in: PubMed
      56. Nguyen S, Choi HK, Lustig RH, Hsu CY. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr. 2009 Jun; 154(6):807-13.
        View in: PubMed
      57. Lo L, Liu KD, Hsu CY. Long-term outcomes after acute kidney injury: where we stand and how we can move forward. Am J Kidney Dis. 2009 Jun; 53(6):928-31.
        View in: PubMed
      58. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009 Feb 23; 169(4):342-50.
        View in: PubMed
      59. Grubbs V, Gregorich SE, Perez-Stable EJ, Hsu CY. Health literacy and access to kidney transplantation. Clin J Am Soc Nephrol. 2009 Jan; 4(1):195-200.
        View in: PubMed
      60. Bansal N, Hsu CY. Long-term outcomes of patients with chronic kidney disease. Nat Clin Pract Nephrol. 2008 Oct; 4(10):532-3.
        View in: PubMed
      61. Hsu CY. FGF-23 and outcomes research--when physiology meets epidemiology. N Engl J Med. 2008 Aug 7; 359(6):640-2.
        View in: PubMed
      62. Xie D, Joffe MM, Brunelli SM, Beck G, Chertow GM, Fink JC, Greene T, Hsu CY, Kusek JW, Landis R, Lash J, Levey AS, O'Conner A, Ojo A, Rahman M, Townsend RR, Wang H, Feldman HI. A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1332-8.
        View in: PubMed
      63. Padilla J, Krasnoff J, Da Silva M, Hsu CY, Frassetto L, Johansen KL, Painter P. Physical functioning in patients with chronic kidney disease. J Nephrol. 2008 Jul-Aug; 21(4):550-9.
        View in: PubMed
      64. Hsu J, Johansen KL, Hsu CY, Kaysen GA, Chertow GM. Higher serum creatinine concentrations in black patients with chronic kidney disease: beyond nutritional status and body composition. Clin J Am Soc Nephrol. 2008 Jul; 3(4):992-7.
        View in: PubMed
      65. Hsu CY, Ordoñez JD, Chertow GM, Fan D, McCulloch CE, Go AS. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008 Jul; 74(1):101-7.
        View in: PubMed
      66. Nguyen S, McCulloch C, Brakeman P, Portale A, Hsu CY. Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents. Pediatrics. 2008 Jan; 121(1):37-45.
        View in: PubMed
      67. Hsu CY, McCulloch CE, Fan D, Ordoñez JD, Chertow GM, Go AS. Community-based incidence of acute renal failure. Kidney Int. 2007 Jul; 72(2):208-12.
        View in: PubMed
      68. Hsu CY. Linking the population epidemiology of acute renal failure, chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens. 2007 May; 16(3):221-6.
        View in: PubMed
      69. Nguyen S, Hsu CY. Excess weight as a risk factor for kidney failure. Curr Opin Nephrol Hypertens. 2007 Mar; 16(2):71-6.
        View in: PubMed
      70. Joff MM, Small D, Hsu CY. Statist Sci. Defining and estimating intervention effects for groups that will develop an auxiliary outcome. 2007; 22(1):74-97.
      71. Hsu CY, Go AS, McCulloch CE, Darbinian J, Iribarren C. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease. Clin J Am Soc Nephrol. 2007 Jan; 2(1):81-8.
        View in: PubMed
      72. Hsu CY. Review: healthy kidney donors may have a long-term increase in blood pressure beyond that associated with normal aging. ACP J Club. 2006 Nov-Dec; 145(3):79.
        View in: PubMed
      73. Hsu CY. Benazepril was effective and safe for advanced chronic kidney disease without diabetes. ACP J Club. 2006 Jul-Aug; 145(1):19.
        View in: PubMed
      74. Chertow GM, Hsu CY, Johansen KL. The enlarging body of evidence: obesity and chronic kidney disease. J Am Soc Nephrol. 2006 Jun; 17(6):1501-2.
        View in: PubMed
      75. Hall YN, Hsu CY. New insights into the epidemiology of chronic kidney disease in US Asians and Pacific Islanders. Curr Opin Nephrol Hypertens. 2006 May; 15(3):264-9.
        View in: PubMed
      76. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006 Jan 3; 144(1):21-8.
        View in: PubMed
      77. Gorodetskaya I, Zenios S, McCulloch CE, Bostrom A, Hsu CY, Bindman AB, Go AS, Chertow GM. Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int. 2005 Dec; 68(6):2801-8.
        View in: PubMed
      78. Hall YN, Hsu CY, Iribarren C, Darbinian J, McCulloch CE, Go AS. The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int. 2005 Nov; 68(5):2310-6.
        View in: PubMed
      79. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005 Apr 25; 165(8):923-8.
        View in: PubMed
      80. Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005 Mar; 67(3):1047-52.
        View in: PubMed
      81. Shah SJ, Hsu CY. Has acetylcysteine use changed the incidence of contrast nephropathy in hospitalized patients? A before-after study. Am J Med. 2004 Dec 15; 117(12):948-52.
        View in: PubMed
      82. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 Sep 23; 351(13):1296-305.
        View in: PubMed
      83. Hsu CY, Vittinghoff E, Lin F, Shlipak MG. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med. 2004 Jul 20; 141(2):95-101.
        View in: PubMed
      84. Hsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003 Nov; 14(11):2902-7.
        View in: PubMed
      85. Chen ML, Hsu CY. Should the K/DOQI definition of chronic kidney disease be changed? Am J Kidney Dis. 2003 Oct; 42(4):623-5.
        View in: PubMed
      86. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL, He J, Hostetter T, Hsu CY, Jamerson K, Joffe M, Kusek JW, Landis JR, Lash JP, Miller ER, Mohler ER, Muntner P, Ojo AO, Rahman M, Townsend RR, Wright JT. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S148-53.
        View in: PubMed
      87. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003 Jun 25; 289(24):3273-7.
        View in: PubMed
      88. Hsu CY, McCulloch CE, Curhan GC. Iron status and hemoglobin level in chronic renal insufficiency. J Am Soc Nephrol. 2002 Nov; 13(11):2783-6.
        View in: PubMed
      89. De Boer IH, Gorodetskaya I, Young B, Hsu CY, Chertow GM. The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol. 2002 Nov; 13(11):2762-9.
        View in: PubMed
      90. Hsu CY, Chertow GM. Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant. 2002 Aug; 17(8):1419-25.
        View in: PubMed
      91. Hsu CY, Chertow GM, Curhan GC. Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int. 2002 May; 61(5):1567-76.
        View in: PubMed
      92. Hsu CY, Cummings SR, McCulloch CE, Chertow GM. Bone mineral density is not diminished by mild to moderate chronic renal insufficiency. Kidney Int. 2002 May; 61(5):1814-20.
        View in: PubMed
      93. Hsu CY, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2002 Feb; 13(2):504-10.
        View in: PubMed
      94. Hsu CY, Bates DW, Kuperman GJ, Curhan GC. Blood pressure and angiotensin converting enzyme inhibitor use in hypertensive patients with chronic renal insufficiency. Am J Hypertens. 2001 Dec; 14(12):1219-25.
        View in: PubMed
      95. Hsu CY, Bates DW, Kuperman GJ, Curhan GC. Relationship between hematocrit and renal function in men and women. Kidney Int. 2001 Feb; 59(2):725-31.
        View in: PubMed
      96. Hsu CY. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials. J Hum Hypertens. 2001 Feb; 15(2):99-106.
        View in: PubMed
      97. Hsu CY, Chertow GM. Chronic renal confusion: insufficiency, failure, dysfunction, or disease. Am J Kidney Dis. 2000 Aug; 36(2):415-8.
        View in: PubMed
      98. Hsu CY, Bates DW, Kuperman GJ, Curhan GC. Diabetes, hemoglobin A(1c), cholesterol, and the risk of moderate chronic renal insufficiency in an ambulatory population. Am J Kidney Dis. 2000 Aug; 36(2):272-81.
        View in: PubMed
      Chi-yuan's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP